| |
| |
|
| Insider
Information: |
Ruffo Frank |
| Relationship: |
Chief Financial Officer |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
201,883 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$224,090 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
201,883 |
|
|
| Total
Value |
$224,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -21.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Financial Officer |
2022-03-10 |
201,883 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial OfficerOfficer |
• – – |
2015-10-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
130,434 |
|
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2015-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,478 |
137,912 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2016-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,790 |
142,702 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2016-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
143,952 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2016-12-18 |
4 |
D |
$31.25 |
$11,875 |
D/D |
(380) |
143,572 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-12-15 |
4 |
D |
$24.23 |
$9,571 |
D/D |
(395) |
144,477 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
144,872 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
145,727 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
D |
$24.12 |
$9,166 |
D/D |
(380) |
145,347 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,018 |
154,365 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-04-06 |
4 |
AB |
$16.59 |
$20,738 |
D/D |
1,250 |
155,615 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-05-07 |
4 |
D |
$18.10 |
$26,788 |
D/D |
(1,480) |
160,585 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,200 |
162,065 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-05-07 |
4 |
AB |
$18.22 |
$22,775 |
D/D |
1,250 |
156,865 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
161,885 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-12-15 |
4 |
D |
$7.31 |
$2,705 |
D/D |
(370) |
161,515 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
162,765 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2018-12-18 |
4 |
D |
$6.30 |
$2,243 |
D/D |
(356) |
162,409 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-02-01 |
4 |
D |
$6.96 |
$9,104 |
D/D |
(1,308) |
164,976 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,875 |
166,284 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
166,276 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-16 |
4 |
D |
$1.80 |
$666 |
D/D |
(370) |
165,906 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
167,156 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-18 |
4 |
D |
$1.81 |
$644 |
D/D |
(356) |
166,800 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-02-03 |
4 |
D |
$1.28 |
$1,674 |
D/D |
(1,308) |
169,367 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
